Labshake search
Citations for Tocris :
101 - 150 of 938 citations for 6 Nitro 2 oxo 2H chromene 3 carboxylic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2019Quote: ... and 50 µM D-2-amino-5-phosphonovaleric acid (D-AP-5; Tocris) to isolate synaptic inhibitory transmission ...
-
bioRxiv - Neuroscience 2023Quote: ... and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV, Tocris, 0106) to block glutamatergic inputs ...
-
bioRxiv - Neuroscience 2023Quote: ... DL-2- amino-5-phosphono-pentanoic acid (AP5; 50 µM; Tocris, Item# 0105), 4-Aminopyridine (4- AP ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX and D(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) were from Tocris Biosciences ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDAR antagonist D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50µM, Tocris-0106) and tetrodotoxin (TTX ...
-
bioRxiv - Genomics 2021Quote: ... neurons were made quiescent for 2 hours with 100 μM D-2- amino-5-phosphonopentanoic acid (D-AP5; Tocris #0106) and 1 μM tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the bath through the perfusion system for 10 minutes before recordings ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the Ames medium before recordings.
-
bioRxiv - Neuroscience 2020Quote: ... DL-2-Amino-5-phosphonopentanoic acid sodium salt (AP5, Cat. No. 3693, Tocris, UK), (-)-Bicuculline methochloride (Cat ...
-
bioRxiv - Neuroscience 2022Quote: ... and L-2-amino-5-phosphonopentanoic acid (APV, an NMDA receptor blocker) from Tocris. APV ...
-
bioRxiv - Neuroscience 2023Quote: ... and 50 μM 2-amino-5-phosphonopentanoic acid (D-AP5; Tocris Bioscience, Cambridge, UK) to avoid spontaneous network activation ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5, TOCRIS bioscience #0105). NH4Cl perfusions were done with 50 mM NH4Cl in substitution of 50 mM NaCl (pH 7.4) ...
-
bioRxiv - Neuroscience 2024Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 mM, Tocris Bioscience, Bristol, UK) was added.
-
bioRxiv - Neuroscience 2020Quote: ... 1-[2-(4-Methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl-1H-imidazole hydrochloride (SKF-96365; 1147, Tocris) in ddH20 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... 2-[[6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy) phenyl]-2-pyridinyl]thio]-acetamide (BAY 60-6583; Tocris, 910487-58-0), 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide (2-Chloro-IB-MECA ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ST034307 (6-Chloro-2-(trichloromethyl)-4H-1-benzopyran-4-one) was purchased from Tocris Bioscience and morphine sulphate from Spectrum Laboratory Products ...
-
bioRxiv - Cell Biology 2022Quote: The following drugs were applied for 2h in serum free medium: Y27632 (10 μm; Tocris); Blebbistatin (5 μm ...
-
bioRxiv - Neuroscience 2021Quote: ... 1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid (BAPTA, 50 µM, Tocris); and 1,2-Bis(2-aminophenoxy)ethane-N,N,N’,N’-tetra-acetic acid tetrakis (acetoxymethylester ...
-
bioRxiv - Neuroscience 2021Quote: ... 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5, 0106, Tocris Bioscience, UK), and 10 μM of SR95531 (SR ...
-
bioRxiv - Neuroscience 2021Quote: ... mEPSCs were recorded in aCSF supplemented with 10 μM N-[3-[4-(3-Aminopropylamino)butylamino]propyl]-2-naphthalen-1-ylacetamide trihydrochloride (NASPM, Tocris) to selectively block CP-AMPARs ...
-
bioRxiv - Neuroscience 2023Quote: ... P3029) and 2-methyl-6-(phenylethynyl)pyridine (MPEP; Tocris, Ellisville, MO, Cat. No. 1212/10), solutions were made fresh in sterile saline before use ...
-
bioRxiv - Neuroscience 2021Quote: ... 6R)-4-Amino-2-oxabicyclo [3.1.0] hexane-4,6-dicarboxylic acid disodium salt (LY379268, 100 µM, Tocris); calmidazolium chloride (CMZ ...
-
bioRxiv - Cancer Biology 2022Quote: ... 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... JNJ16259685 and 2-Methyl-6-(phenylethynyl)pyridine (MPEP) hydrochloride were purchased from Tocris (Minneapolis MN, USA). (±)-Sulpiride was purchased from MilliporeSigma ...
-
bioRxiv - Cell Biology 2024Quote: ... Cultures were passaged every 6 days and kept in a cycle of 3 days in 5μM ROCK inhibitor (Y-27632 dihydrochloride; Tocris), 3 days in the absence of rock inhibitor ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2021Quote: ... synaptic GABA currents were recorded in perfusing aCSF containing the glutamate receptor antagonist kynurenic acid (3 mM, Tocris, Ellisville, MO). Recorded neurons were initially held at −70 mV for interneurons and −60 mV for GCs and SGCs and the response to 500 milli-second positive and negative current injections were examined to determine active and passive characteristics ...
-
bioRxiv - Physiology 2023Quote: ... PAH was induced by a single subcutaneous injection of SU5416 (SU:3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydroindol-2-one) (Tocris, Bristol, United Kingdom) in 0.5% carboxymethyl cellulose followed by 3-weeks chronic hypoxia (9-10% O2) ...
-
bioRxiv - Neuroscience 2023Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience) in ACSF at 31-33°C as previously (18) ...
-
bioRxiv - Neuroscience 2020Quote: ... The following agents were used: L-(+)-2-amino-4-phophonobutyric acid (L-AP4; 20μM; Tocris Bioscience, catalog #0103), D-(-)-2-amino-5-phophonopentanoic acid (D-AP5 ...
-
bioRxiv - Cancer Biology 2023Quote: ... N-(1,3,4-thiadiazol-2-yl) pyridine-3-carboxamide dihydrochloride (TGN-020, Tocris Cat No 5425) was used in vitro at 10-100 μM ...
-
Pathogenic CD8 T cell responses are driven by neutrophil-mediated hypoxia in cutaneous leishmaniasisbioRxiv - Immunology 2023Quote: ... the sections were counter-stained with the nuclear probe 4’,6-diamino-2-phenylindole (DAPI, Biotechne-Tocris, UK). Slides were covered with Prolong™ Gold Antifade Mountant (Invitrogen ...
-
bioRxiv - Neuroscience 2020Quote: ... co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris; 20 μM) (n=13) ...
-
bioRxiv - Neuroscience 2021Quote: ... d-2-Amino-5-phosphonovaleric acid (d-AP5, 50µM) and the sodium (Na+) channel blocker tetrodotoxin (TTX, 1 µM Tocris). Individual traces (5 sec duration ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2020Quote: ... 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 20 μM D-(-)-2-amino-5-phosphopentanoic acid (D-AP5) (Tocris Bioscience) to block glycine- ...
-
bioRxiv - Neuroscience 2024Quote: 6-hydroxydopamine (Tocris) injections were performed in WT mice at 8-9 weeks of age ...
-
bioRxiv - Neuroscience 2022Quote: ... food was removed for 3 hours (3 pm – 6 pm) and mice received either vehicle or CCK-8s (20 μg/kg BW; i.p.; Tocris, St. Louis, USA) injection at dark onset (6 pm ...
-
Safety and efficacy of C9ORF72-repeat RNA nuclear export inhibition in amyotrophic lateral sclerosisbioRxiv - Systems Biology 2021Quote: ... supplemented with SMAD inhibitors (DMH-1 2 µM; SB431542-10 µM and CHIR99021 3 µM [ [Tocris]). The medium was changed every day for 6 days ...
-
bioRxiv - Neuroscience 2020Quote: ... Readings were taken before and 3–4 min after application of 20 μM 2-AG (Tocris) to activate CB1R or the eCB sensor.
-
bioRxiv - Neuroscience 2021Quote: ... 3-((±)2-carboxypiperazin-4yl) propyl-1-phosphate (CPP, NMDA receptor antagonist, 20 μM; Tocris Bioscience, UK) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Neuroscience 2023Quote: ... followed by seven days medium d3–9 (Medium d1-2 with 3 µM CHIR99021 [Tocris, 4423]), one day of medium d10 (Medium d3–9 with 200 µM ascorbic acid [Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2019Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience, Bristol, UK). Inhibitors were applied concomitantly from 30 min before to 30 min after DHPG/MPEP treatment ...
-
bioRxiv - Neuroscience 2021Quote: ... The mGluR5 specific negative allosteric modulator MPEP hydrochloride (2-Methyl-6-(phenylethynyl)pyridine hydrochloride) was purchased from Tocris (1212) and administered to brain slices at 30 μM by bath perfusion ...
-
bioRxiv - Neuroscience 2021Quote: ... quisqualic acid (QA – Tocris), and N-methyl-D-aspartic acid (NMDA ...
-
bioRxiv - Neuroscience 2021Quote: ... kainic acid (Tocris 0222), Ph-KA (made in-house) ...
-
bioRxiv - Neuroscience 2020Quote: ... flufenamic acid (4522, Tocris), nifedipine (1075 ...
-
bioRxiv - Neuroscience 2024Quote: ... Valproic acid (0.5mM, Tocris) was added on day 13 ...
-
bioRxiv - Neuroscience 2020Quote: ... 0.9% w/v) and 6-OHDA HCl powder (6-hydroxydopamine hydrochloride from Sigma or 6-OHDA hydrobromide from Tocris) was then dissolved to produce a final 6-OHDA concentration of 4.44 mg/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... the AMPA/NMDA receptor agonist kynurenic acid (2 mM) and the GABA-A receptor antagonist picrotoxin (PTX; 100 uM, Tocris) were present ...